Everything you need to know about vaccination against Covid in Romania. 16 questions and answers



[ad_1]

Vaccination against COVID-19 is important because it reduces the risk of illness and the risk of developing a severe form of the disease, according to a document that provides answers to the most important questions people have about administering the vaccine. anti-Covid.

All information is presented and explained on the site. vaccinare-covid.gov.ro.

Why should I get vaccinated against COVID-19?

Vaccination against COVID-19 is important because reduces the risk of disease and the risk of developing a severe form of the disease. Vaccination is an important tool to stop the spread of the pandemic, reduce the overload of health facilities, thus allowing the reopening of health facilities for non-COVID patients. Therefore, the conditions will be created for the reopening of socio-economic activities and the facilitation of free movement.

How is personal data about vaccination against COVID-19 protected?

The monitoring of the level of vaccination coverage, safety and efficacy of vaccines against COVID-19 is carried out through electronic platforms, in compliance with the legislation on protection of personal data.

According to the vaccination strategy against COVID-19 in Romania, a module dedicated to vaccination against COVID-19 within the National Electronic Vaccination Registry (RENV), which will constitute the electronic database on vaccination, in compliance with the legal provisions on personal data protection.

What document will be issued at the time of vaccination?

Each person to be vaccinated will receive one certificate vaccination evidence that will include the following information: first and last name of the vaccinated person, date of birth, age, county of residence, IC number and series, vaccine data: dose 1 (type of vaccine, product, series / lot , expiration date), dose 2 (type of vaccine, product, series / batch, expiration date), data on the vaccination center (name of the vaccination center, district, coordinating doctor / vaccinator), electronic signature of the National Registry Electronic Vaccination.

Proof of vaccination is provided to the vaccinated person, either in electronic or paper format, so that they can keep a record between the two visits to the vaccination center (initial dose and booster) and provide essential information on the characteristics of the vaccination. administered vaccine. . We specify that vaccination is free, voluntary / optional, and the test is not issued to condition or restrict the rights of vaccinated persons.

If I have been infected with SARS-CoV-2, do I still need the vaccine?

In clinical trials, the vaccine was also given to people who had a detectable level of anti-SARS-CoV-2 antibodies and no side effects were detected, just an increase in immune response. Vaccination is available, based on consent, whether or not there is infection.

How can I get information about possible vaccines?

At the European Union level, the vaccines to be used in vaccination campaigns against COVID-19 are those that have received approval from the European Medicines Agency. All details about the evaluation and approval process are available and constantly updated on the website of the European Medicines Agency.

Who do I contact if I want to get vaccinated?

According to the Vaccination Strategy against COVID-19 in Romania, vaccination will be carried out in stages, respecting the population groups. For stage I, vaccination will be organized at work and through fixed and mobile vaccination centers, and for stages II and III vaccination will be organized through fixed and mobile vaccination centers, mobile teams, family medicine network , driving centers. -through.

Can I refuse to get vaccinated?

Yes, according to the vaccination strategy against COVID-19 in Romania, vaccination is voluntary and non-binding.

Is vaccination free?

GivesAccording to the vaccination strategy against COVID-19 in Romania, vaccination is free.

If I get vaccinated, is it still necessary to respect the other hygienic-sanitary measures?

The administration of a vaccine against COVID-19 is one of the critical tools to limit the effects of the pandemic, along with other tools: compliance with restrictions and hygiene measures (use of mask, hand washing and physical distance).

Are people with pre-existing medical conditions eligible for vaccination?

According to the national vaccination strategy against COVID-19, people with chronic diseases, regardless of age, have priority for vaccination, taking into account the indications and contraindications of the vaccines used.

Can a person who has been infected with SARS-CoV-2 be vaccinated?

Gives, a person who has been infected with SARS-CoV-2 can be vaccinated voluntarily when they meet the prioritization criteria. It is not intended to exclude people with a known prior infection from vaccination or to test people before vaccination.

It is currently unknown how long after infection we are protected or the level of antibodies necessary to be protected. Recent studies show that in most people, neutralizing antibodies (those that can block cell infection) persist for at least a few months after the initial infection. Studies also show that the immune response to natural infection can vary greatly depending on the individual and the severity of the disease.

Regulators do not recommend excluding participants in phase 3 clinical trials based on evidence of prior infection, so most manufacturers have already vaccinated people who have been through the disease without reporting any effects severe secondary.

What are self-service vaccination centers?

Drive-through vaccination centers are fixed vaccination centers specially designed for the third stage of the vaccination process, which is aimed at the general population. In accordance with the recommendations of the World Health Organization, the organization and arrangement of these centers will be done in large urban agglomerations, in areas that allow access for people with their own vehicles. The organization and arrangement of the drive-through vaccination centers will be carried out in accordance with all the safety and hygiene regulations, in order to facilitate people’s access to vaccination, speed up the vaccination process, avoid overcrowding or overcrowding. sacrifice of vaccine doses. The organization of such transit centers is proposed by the strategy of the World Health Organization.

What are mobile vaccination centers?

Mobile vaccination centers are mobile vaccination centers / caravans organized at different stages of the vaccination process. The organization and provision of these mobile vaccination centers will be carried out, when necessary, to facilitate access to vaccination for people who attend essential activities, people in residential and medical and social centers and, where appropriate, people of the population. for which access to vaccination is limited. The organization and arrangement of the mobile vaccination centers will be carried out in compliance with all safety and hygiene regulations, in order to facilitate access to vaccination, speed up the vaccination process, avoid overcrowding or sacrifice vaccine doses.

What is a conditional marketing authorization (CMA)?

Within the European Union, a conditional marketing authorization allows the authorization of medicines that address a need not yet covered, based on less complete data than is normally required. This happens in public health emergencies, such as the Covid-19 pandemic, only if the benefits outweigh the potential risks posed by the fact that not all data is available yet. Conditional authorizations are used in the event of the Covid-19 pandemic to respond to the public health emergency. Still, the data provided should clearly indicate that the benefits of the drug or vaccine outweigh the potential risks. The requirement that the benefits be much greater in relation to the possible risks is all the more explicit in the case of vaccines to be administered to healthy people. Once such conditional authorization has been issued, companies must provide more data, from ongoing studies or new studies, by predetermined deadlines, to further demonstrate that the benefits outweigh the risks.

What happens after a company applies for a marketing authorization for a vaccine?

If the European Medicines Agency concludes that the benefits of the vaccine outweigh the risks, it will recommend that the European Commission grant a conditional marketing authorization. The Commission will then speed up the decision-making procedures and within days the authorization could be taken at the level of the EU Member States and the EEA States.

As with other medicines, EU regulators will continue to collect and evaluate new information after marketing and will take action if necessary. Respecting the European plan for monitoring the safety of vaccines against COVID-19, Monitoring will be done more frequently and will include specific activities for these vaccines. For example, in addition to the regular updates required by law, companies will provide monthly safety monitoring reports and conduct studies to monitor the safety and efficacy of COVID-10 vaccines, even after authorization. These measures will allow regulators to evaluate data from different sources and take the necessary measures to protect public health, where appropriate.

How do the vaccines for which marketing authorizations have been submitted work? (BNT162b2 and RNA1273)

Vaccines will prepare the human body to defend itself against COVID-19. To enter the body and cause disease, the SARS-CoV-2 virus uses a protein in its shell, a protein called protein S (spike). The vaccines contain the genetic instructions (messenger RNA) necessary to generate protein S.

When a person is vaccinated, their cells will “read” the genetic instructions of the messenger RNA and synthesize the S protein. The person’s immune system will recognize this protein as foreign and will activate the immune defense mechanisms, producing antibodies and specific T cells. If the vaccinated person later comes into contact with the SARS-CoV-2 virus, their immune system will recognize the virus and, through specific antibodies and T cells, will neutralize the virus, thus preventing it from entering the healthy cells of the body. destroying any infected cells. This will ensure protection against COVID-19.

Publisher: Georgiana Marina

[ad_2]